BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



Figure 4. Actuarial prostate-specific antigen (PSA) relapse-free survival according to biopsy Gleason score. PSA-RFS is 78.3%, 66.5%, and 56.4% for patients cohorts of Gleason score less than 7, equal 7, and greater than 7, respectively (p<0.001) (solid line, Gleason<7; dashed Gleason=7; dotted Gleason>7). Gleason score is a predictive factor of PSA control.





Right arrow Return to article

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS